世界の幹細胞市場の規模は、2024年に151億￥ドルと推定され、2025年から2030年にかけて11.41%のCAGRで成長すると予想されます。精密医療の発展、細胞治療生産施設の数の増加、臨床試験の数の増加が、市場の主要な推進要因になります。幹細胞治療と組織工学の最近の進歩は、いくつかの疾患の治療に注目を集める可能性を秘めています。さらに、幹細胞バンキングの需要の増加と、幹細胞の生産、保管、および特性評価に関する研究活動の増加も、市場の収益成長を促進すると予想されます。幹細胞の使用に関する親市場および補助市場における技術的改善も、予測期間中に予想される幹細胞の需要の伸びを強化する要因です。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Segment
1.1.2. Application Segment
1.1.3. Technology Segment
1.1.4. Therapy Segment
1.1.5. End-use Segment
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List Of Secondary Sources
1.8. List Of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Ongoing Developments In Regenerative Medicine
3.2.1.2. Rising Funds For Accelerating Stem Cell Research
3.2.1.3. Growing Demand For Stem Cell Banking
3.2.1.4. Increasing Prevalence Of Genetic Disorders and Cancer
3.2.2. Market Restraint And Challenges Analysis
3.2.2.1. Ethical Concern Related To Stem Cell Research
3.2.2.2. Lack Of A Well-Defined Regulatory Framework In Certain Applications Of Stem Cell
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Stem Cells Market: Product Movement Analysis
4.2. Adult Stem Cells (ASCs)
4.2.1. Adult Stem Cells (ASCs) Market, 2018 - 2030 (USD Billion)
4.2.2. Hematopoietic
4.2.2.1. Hematopoietic Market, 2018 - 2030 (USD Billion)
4.2.3. Mesenchymal
4.2.3.1. Mesenchymal Market, 2018 - 2030 (USD Billion)
4.2.4. Neural
4.2.4.1. Neural Market, 2018 - 2030 (USD Billion)
4.2.5. Epithelial/Skin
4.2.5.1. Epithelial/Skin Market, 2018 - 2030 (USD Billion)
4.2.6. Others
4.2.6.1. Others Market, 2018 - 2030 (USD Billion)
4.3. Human Embryonic Stem Cells (HESCs)
4.3.1. Human Embryonic Stem Cells (HESCs) Market, 2018 - 2030 (USD Billion)
4.4. Induced Pluripotent Stem Cells (iPSCs)
4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2018 - 2030 (USD Billion)
4.5. Very Small Embryonic Like Stem Cells
4.5.1. Very Small Embryonic Like Stem Cells Market, 2018 - 2030 (USD Billion)
Chapter 5. Application Business Analysis
5.1. Stem Cells Market: Application Movement Analysis
5.2. Regenerative Medicine
5.2.1. Regenerative Medicine Market, 2018 - 2030 (USD Billion)
5.2.2. Neurology
5.2.2.1. Neurology Market, 2018 - 2030 (USD Billion)
5.2.3. Orthopedics
5.2.3.1. Orthopedics Market, 2018 - 2030 (USD Billion)
5.2.4. Oncology
5.2.4.1. Oncology Market, 2018 - 2030 (USD Billion)
5.2.5. Hematology
5.2.5.1. Hematology Market, 2018 - 2030 (USD Billion)
5.2.6. Cardiovascular and Myocardial Infraction
5.2.6.1. Cardiovascular and Myocardial Infraction Market, 2018 - 2030 (USD Billion)
5.2.7. Injuries
5.2.7.1. Injuries Market, 2018 - 2030 (USD Billion)
5.2.8. Diabetes
5.2.8.1. Diabetes Market, 2018 - 2030 (USD Billion)
5.2.9. Liver Disorder
5.2.9.1. Liver Disorder Market, 2018 - 2030 (USD Billion)
5.2.10. Incontinence
5.2.10.1. Incontinence Market, 2018 - 2030 (USD Billion)
5.2.11. Others
5.2.11.1. Others Market, 2018 - 2030 (USD Billion)
5.3. Drug Discovery and Development
5.3.1. Drug Discovery and Development Market, 2018 - 2030 (USD Billion)
Chapter 6. Technology Business Analysis
6.1. Stem Cells Market: Technology Movement Analysis
6.2. Cell Acquisition
6.2.1. Cell Acquisition Market, 2018 - 2030 (USD Billion)
6.2.2. Bone Marrow Harvest
6.2.2.1. Bone Marrow Harvest Market, 2018 - 2030 (USD Billion)
6.2.3. Umbilical Blood Cord
6.2.3.1. Umbilical Blood Cord Market, 2018 - 2030 (USD Billion)
6.2.4. Apheresis
6.2.4.1. Apheresis Market, 2018 - 2030 (USD Billion)
6.3. Cell Production
6.3.1. Cell Production Market, 2018 - 2030 (USD Billion)
6.3.2. Therapeutic Cloning
6.3.2.1. Therapeutic Cloning Market, 2018 - 2030 (USD Billion)
6.3.3. In-vitro Fertilization
6.3.3.1. In-vitro Fertilization Market, 2018 - 2030 (USD Billion)
6.3.4. Cell Culture
6.3.4.1. Cell Culture Market, 2018 - 2030 (USD Billion)
6.3.5. Isolation
6.3.5.1. Isolation Market, 2018 - 2030 (USD Billion)
6.4. Cryopreservation
6.4.1. Cryopreservation Market, 2018 - 2030 (USD Billion)
6.5. Expansion and Sub-Culture
6.5.1. Expansion and Sub-Culture Market, 2018 - 2030 (USD Billion)
Chapter 7. Therapy Business Analysis
7.1. Stem Cells Market: Therapy Movement Analysis
7.2. Autologous
7.2.1. Autologous Market, 2018 - 2030 (USD Billion)
7.3. Allogeneic
7.3.1. Allogeneic Market, 2018 - 2030 (USD Billion)
Chapter 8. Application Business Analysis
8.1. Stem Cells Market: Application Movement Analysis
8.2. Infectious Diseases
8.2.1. Infectious Diseases Market, 2018 - 2030 (USD Billion)
8.3. Immunology
8.3.1. Immunology Market, 2018 - 2030 (USD Billion)
8.4. Oncology
8.4.1. Oncology Market, 2018 - 2030 (USD Billion)
8.5. Stem Cells
8.5.1. Stem Cells Market, 2018 - 2030 (USD Billion)
8.6. Neurobiology
8.6.1. Neurobiology Market, 2018 - 2030 (USD Billion)
8.7. Others
8.7.1. Other Applications Market, 2018 - 2030 (USD Billion)
Chapter 9. End Use Business Analysis
9.1. Stem Cells Market: End-use Movement Analysis
9.2. Pharmaceutical and Biotechnology Companies
9.2.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Billion)
9.3. Hospitals & Cell Banks
9.3.1. Hospitals & Cell Banks Market, 2018 - 2030 (USD Billion)
9.4. Academic & Research Institutes
9.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Billion)
Chapter 10. Regional Business Analysis
10.1. Stem Cells Market Share By Region, 2025 & 2030
10.2. North America
10.2.1. North America Stem Cells Market, 2018 - 2030 (USD Billion)
10.2.2. U.S.
10.2.2.1. Key Country Dynamics
10.2.2.2. Target Disease Prevalence
10.2.2.3. Competitive Scenario
10.2.2.4. Regulatory Framework
10.2.2.5. U.S. Stem Cells Market, 2018 - 2030 (USD Billion)
10.2.3. Canada
10.2.3.1. Key Country Dynamics
10.2.3.2. Target Disease Prevalence
10.2.3.3. Competitive Scenario
10.2.3.4. Regulatory Framework
10.2.3.5. Canada Stem Cells Market, 2018 - 2030 (USD Billion)
10.2.4. Mexico
10.2.4.1. Key Country Dynamics
10.2.4.2. Target Disease Prevalence
10.2.4.3. Competitive Scenario
10.2.4.4. Regulatory Framework
10.2.4.5. Mexico Stem Cells Market, 2018 - 2030 (USD Billion)
10.3. Europe
10.3.1. Europe Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.2. UK
10.3.2.1. Key Country Dynamics
10.3.2.2. Target Disease Prevalence
10.3.2.3. Competitive Scenario
10.3.2.4. Regulatory Framework
10.3.2.5. UK Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.3. Germany
10.3.3.1. Key Country Dynamics
10.3.3.2. Target Disease Prevalence
10.3.3.3. Competitive Scenario
10.3.3.4. Regulatory Framework
10.3.3.5. Germany Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.4. France
10.3.4.1. Key Country Dynamics
10.3.4.2. Target Disease Prevalence
10.3.4.3. Competitive Scenario
10.3.4.4. Regulatory Framework
10.3.4.5. France Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.5. Italy
10.3.5.1. Key Country Dynamics
10.3.5.2. Target Disease Prevalence
10.3.5.3. Competitive Scenario
10.3.5.4. Regulatory Framework
10.3.5.5. Italy Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.6. Spain
10.3.6.1. Key Country Dynamics
10.3.6.2. Target Disease Prevalence
10.3.6.3. Competitive Scenario
10.3.6.4. Regulatory Framework
10.3.6.5. Spain Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.7. Denmark
10.3.7.1. Key Country Dynamics
10.3.7.2. Target Disease Prevalence
10.3.7.3. Competitive Scenario
10.3.7.4. Regulatory Framework
10.3.7.5. Denmark Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.8. Sweden
10.3.8.1. Key Country Dynamics
10.3.8.2. Target Disease Prevalence
10.3.8.3. Competitive Scenario
10.3.8.4. Regulatory Framework
10.3.8.5. Sweden Stem Cells Market, 2018 - 2030 (USD Billion)
10.3.9. Norway
10.3.9.1. Key Country Dynamics
10.3.9.2. Target Disease Prevalence
10.3.9.3. Competitive Scenario
10.3.9.4. Regulatory Framework
10.3.9.5. Norway Stem Cells Market, 2018 - 2030 (USD Billion)
10.4. Asia Pacific
10.4.1. Asia Pacific Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.2. Japan
10.4.2.1. Key Country Dynamics
10.4.2.2. Target Disease Prevalence
10.4.2.3. Competitive Scenario
10.4.2.4. Regulatory Framework
10.4.2.5. Japan Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.3. China
10.4.3.1. Key Country Dynamics
10.4.3.2. Target Disease Prevalence
10.4.3.3. Competitive Scenario
10.4.3.4. Regulatory Framework
10.4.3.5. China Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.4. India
10.4.4.1. Key Country Dynamics
10.4.4.2. Target Disease Prevalence
10.4.4.3. Competitive Scenario
10.4.4.4. Regulatory Framework
10.4.4.5. India Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.5. Australia
10.4.5.1. Key Country Dynamics
10.4.5.2. Target Disease Prevalence
10.4.5.3. Competitive Scenario
10.4.5.4. Regulatory Framework
10.4.5.5. Australia Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.6. Thailand
10.4.6.1. Key Country Dynamics
10.4.6.2. Target Disease Prevalence
10.4.6.3. Competitive Scenario
10.4.6.4. Regulatory Framework
10.4.6.5. Thailand Stem Cells Market, 2018 - 2030 (USD Billion)
10.4.7. South Korea
10.4.7.1. Key Country Dynamics
10.4.7.2. Target Disease Prevalence
10.4.7.3. Competitive Scenario
10.4.7.4. Regulatory Framework
10.4.7.5. South Korea Stem Cells Market, 2018 - 2030 (USD Billion)
10.5. Latin America
10.5.1. Latin America Stem Cells Market, 2018 - 2030 (USD Billion)
10.5.2. Brazil
10.5.2.1. Key Country Dynamics
10.5.2.2. Target Disease Prevalence
10.5.2.3. Competitive Scenario
10.5.2.4. Regulatory Framework
10.5.2.5. Brazil Stem Cells Market, 2018 - 2030 (USD Billion)
10.5.3. Argentina
10.5.3.1. Key Country Dynamics
10.5.3.2. Target Disease Prevalence
10.5.3.3. Competitive Scenario
10.5.3.4. Regulatory Framework
10.5.3.5. Argentina Stem Cells Market, 2018 - 2030 (USD Billion)
10.6. MEA
10.6.1. MEA Stem Cells Market, 2018 - 2030 (USD Billion)
10.6.2. South Africa
10.6.2.1. Key Country Dynamics
10.6.2.2. Target Disease Prevalence
10.6.2.3. Competitive Scenario
10.6.2.4. Regulatory Framework
10.6.2.5. South Africa Stem Cells Market, 2018 - 2030 (USD Billion)
10.6.3. Saudi Arabia
10.6.3.1. Key Country Dynamics
10.6.3.2. Target Disease Prevalence
10.6.3.3. Competitive Scenario
10.6.3.4. Regulatory Framework
10.6.3.5. Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Billion)
10.6.4. UAE
10.6.4.1. Key Country Dynamics
10.6.4.2. Target Disease Prevalence
10.6.4.3. Competitive Scenario
10.6.4.4. Regulatory Framework
10.6.4.5. UAE Stem Cells Market, 2018 - 2030 (USD Billion)
10.6.5. Kuwait
10.6.5.1. Key Country Dynamics
10.6.5.2. Target Disease Prevalence
10.6.5.3. Competitive Scenario
10.6.5.4. Regulatory Framework
10.6.5.5. Kuwait Stem Cells Market, 2018 - 2030 (USD Billion)
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2024
11.4. Company Profiles/Listing
11.4.1. Thermo Fisher Scientific, Inc.
11.4.1.1. Overview
11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. STEMCELL Technologies Inc.
11.4.2.1. Overview
11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.2.3. Product Benchmarking
11.4.2.4. Strategic Initiatives
11.4.3. Merck KGaA
11.4.3.1. Overview
11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.3.3. Product Benchmarking
11.4.3.4. Strategic Initiatives
11.4.4. CellGenix GmbH
11.4.4.1. Overview
11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.4.3. Product Benchmarking
11.4.4.4. Strategic Initiatives
11.4.5. PromoCell GmbH
11.4.5.1. Overview
11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.5.3. Product Benchmarking
11.4.5.4. Strategic Initiatives
11.4.6. Takara Holdings, Inc.
11.4.6.1. Overview
11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.6.3. Product Benchmarking
11.4.6.4. Strategic Initiatives
11.4.7. Lonza
11.4.7.1. Overview
11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.7.3. Product Benchmarking
11.4.7.4. Strategic Initiatives
11.4.8. Cellular Engineering Technologies
11.4.8.1. Overview
11.4.8.2. Product Benchmarking
11.4.8.3. Strategic Initiatives
11.4.9. ATCC
11.4.9.1. Overview
11.4.9.2. Product Benchmarking
11.4.9.3. Strategic Initiatives
11.4.10. AcceGen
11.4.10.1. Overview
11.4.10.2. Product Benchmarking
11.4.10.3. Strategic Initiatives
11.4.11. Cell Applications, Inc.
11.4.11.1. Overview
11.4.11.2. Product Benchmarking
11.4.11.3. Strategic Initiatives
11.4.12. Bio-Techne
11.4.12.1. Overview
11.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
11.4.12.3. Product Benchmarking
11.4.12.4. Strategic Initiatives
List of Tables
TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Global Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 4 Global Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 5 Global Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 6 Global Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 7 Global Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
TABLE 8 Global Stem Cells Market, by Region, 2018 - 2030 (USD Million)
TABLE 9 North America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
TABLE 10 North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 11 North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 12 North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 13 North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 14 North America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 15 U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 16 U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 17 U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 18 U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 19 U.S. Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 20 Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 21 Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 22 Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 23 Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 24 Mexico Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 25 Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 26 Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 27 Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 28 Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 29 Canada Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 30 Europe Stem Cells Market, by Country, 2018 - 2030 (USD Million)
TABLE 31 Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 32 Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 33 Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 34 Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 35 Europe Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 36 Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 37 Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 38 Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 39 Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 40 Germany Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 41 UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 42 UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 43 UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 44 UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 45 UK Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
TABLE 46 France Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 47 France Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 48 France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 49 France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 50 France Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 51 Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 52 Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 53 Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 54 Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 55 Italy Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 56 Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 57 Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 58 Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 59 Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 60 Spain Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 61 Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 62 Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 63 Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 64 Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 65 Denmark Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 66 Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 67 Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 68 Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 69 Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 70 Sweden Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 71 Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 72 Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 73 Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 74 Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 75 Norway Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
TABLE 76 Asia Pacific Stem Cells Market, by Country, 2018 - 2030 (USD Million)
TABLE 77 Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 78 Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 79 Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 80 Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 81 Asia Pacific Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 82 China Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 83 China Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 84 China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 85 China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 86 China Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 87 Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 88 Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 89 Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 90 Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 91 Japan Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 92 India Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 93 India Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 94 India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 95 India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 96 India Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 97 South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 98 South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 99 South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 100 South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 101 South Korea Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 102 Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 103 Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 104 Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 105 Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 106 Australia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 107 Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 108 Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 109 Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 110 Thailand Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 111 Thailand Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 112 Latin America Stem Cells Market, by Country, 2018 - 2030 (USD Million)
TABLE 113 Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 114 Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 115 Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 116 Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 117 Latin America Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 118 Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 119 Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 120 Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 121 Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 122 Brazil Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 123 Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 124 Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 125 Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 126 Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 127 Argentina Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 128 Middle East & Africa Stem Cells Market, by Country, 2018 - 2030 (USD Million)
TABLE 129 Middle East & Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 130 Middle East & Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 131 Middle East & Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 132 Middle East & Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 133 Middle East & Africa Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 134 South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 135 South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 136 South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 137 South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 138 South Africa Stem Cells Market, by End-use, 2018 - 2030 (USD Million)
TABLE 139 Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 140 Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 141 Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 142 Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 143 Saudi Arabia Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 144 UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 145 UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 146 UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 147 UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 148 UAE Stem Cells Market, by End use, 2018 - 2030 (USD Million)
TABLE 149 Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
TABLE 150 Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
TABLE 151 Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
TABLE 152 Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
TABLE 153 Kuwait Stem Cells Market, by End use, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Stem Cells Market Segmentation
FIG. 8 Market Snapshot, 2024
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 PESTEL Analysis
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Global Stem Cells Market: Product Movement Analysis
FIG. 15 Global Stem Cells Market, for Adult Stem Cells, 2018 - 2030 (USD Million)
FIG. 16 Global Stem Cells Market, for Hematopoietic Stem Cells (Blood Stem Cells), 2018 - 2030 (USD Million)
FIG. 17 Global Stem Cells Market, for Mesenchymal Stem Cells, 2018 - 2030 (USD Million)
FIG. 18 Global Stem Cells Market, for Neural Stem Cells, 2018 - 2030 (USD Million)
FIG. 19 Global Stem Cells Market, for Epithelial/Skin Stem Cells, 2018 - 2030 (USD Million)
FIG. 20 Global Stem Cells Market, for Other Adult Stem Cells, 2018 - 2030 (USD Million)
FIG. 21 Global Stem Cells Market, for Human Embryonic Stem Cells, 2018 - 2030 (USD Million)
FIG. 22 Global Stem Cells Market, for Induced Pluripotent Stem Cells, 2018 - 2030 (USD Million)
FIG. 23 Global Stem Cells Market, for Very Small Embryonic Like Stem Cells, 2018 - 2030 (USD Million)
FIG. 24 Global Stem Cells Market: Application Movement Analysis
FIG. 25 Global Stem Cells Market, for Regenerative Medicine, 2018 - 2030 (USD Million)
FIG. 26 Global Stem Cells Market, for Neurology, 2018 - 2030 (USD Million)
FIG. 27 Global Stem Cells Market, for Orthopedics, 2018 - 2030 (USD Million)
FIG. 28 Global Stem Cells Market, for Oncology, 2018 - 2030 (USD Million)
FIG. 29 Global Stem Cells Market, for Hematology, 2018 - 2030 (USD Million)
FIG. 30 Global Stem Cells Market, for Cardiovascular and Myocardial Infraction, 2018 - 2030 (USD Million)
FIG. 31 Global Stem Cells Market, for Injuries, 2018 - 2030 (USD Million)
FIG. 32 Global Stem Cells Market, for Diabetes, 2018 - 2030 (USD Million)
FIG. 33 Global Stem Cells Market, for Liver Disorder, 2018 - 2030 (USD Million)
FIG. 34 Global Stem Cells Market, for Incontinence, 2018 - 2030 (USD Million)
FIG. 35 Global Stem Cells Market, for Others, 2018 - 2030 (USD Million)
FIG. 36 Global Stem Cells Market, for Drug Discovery and Development, 2018 - 2030 (USD Million)
FIG. 37 Global Stem Cells Market: Technology Movement Analysis
FIG. 38 Global Stem Cells Market, for Cell Acquisition, 2018 - 2030 (USD Million)
FIG. 39 Global Stem Cells Market, for Bone Marrow Harvest, 2018 - 2030 (USD Million)
FIG. 40 Global Stem Cells Market, for Umbilical Blood Cord, 2018 - 2030 (USD Million)
FIG. 41 Global Stem Cells Market, for Apheresis, 2018 - 2030 (USD Million)
FIG. 42 Global Stem Cells Market, for Cell Production, 2018 - 2030 (USD Million)
FIG. 43 Global Stem Cells Market, for Therapeutic Cloning, 2018 - 2030 (USD Million)
FIG. 44 Global Stem Cells Market, for In Vitro Fertilization, 2018 - 2030 (USD Million)
FIG. 45 Global Stem Cells Market, for Cell Culture, 2018 - 2030 (USD Million)
FIG. 46 Global Stem Cells Market, for Isolation, 2018 - 2030 (USD Million)
FIG. 47 Global Stem Cells Market, for Cryopreservation, 2018 - 2030 (USD Million)
FIG. 48 Global Stem Cells Market, for Expansion and Sub-Culture, 2018 - 2030 (USD Million)
FIG. 49 Global Stem Cells Market: Therapy Movement Analysis
FIG. 50 Global Stem Cells Market, for Autologous, 2018 - 2030 (USD Million)
FIG. 51 Global Stem Cells Market, for Allogeneic, 2018 - 2030 (USD Million)
FIG. 52 Global Stem Cells Market, End-User Movement Analysis
FIG. 53 Global Stem Cells Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
FIG. 54 Global Stem Cells Market, for Hospitals & Cell Banks, 2018 - 2030 (USD Million)
FIG. 55 Global Stem Cells Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 56 Regional Outlook, 2024 & 2030
FIG. 57 Global Stem Cells Market: Region Movement Analysis
FIG. 58 North America Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 59 U.S. Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 60 Canada Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 61 Europe Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 62 Germany Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 63 UK Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 64 France Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 65 Italy Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 66 Spain Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 67 Denmark Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 68 Norway Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 69 Sweden Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 70 Asia Pacific Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 71 Japan Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 72 China Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 73 India Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 74 Australia Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 75 South Korea Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 76 Thailand Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 77 Latin America Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 78 Brazil Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 79 Mexico Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 80 Argentina Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 81 Middle East and Africa Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 82 South Africa Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 83 Saudi Arabia Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 84 UAE Stem Cells Market, 2018 - 2030 (USD Million)
FIG. 85 Kuwait Stem Cells Market, 2018 - 2030 (USD Million)
